Real-time enrollment status for this advanced breast cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:06 PM UTC
| NCT Number | NCT07318805 |
| Recruiting Status | Recruiting |
| Condition | Advanced Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 260 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of October 12, 2026: Clinical trial NCT07318805 is currently recruiting participants. This phase1 study for advanced breast cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07318805 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07318805 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.